Itau Unibanco Holding S.A.
ARCT icon

Itau Unibanco Holding S.A.’s Arcturus Therapeutics ARCT Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,111
Closed -$26.6K – 515
2023
Q1 		$26.6K Sell
1,111
-8
-0.7% -$144 ﹤0.01% 377
2022
Q4 		$19K Sell
1,119
-505
-31% -$8.8K ﹤0.01% 398
2022
Q3 		$24K Sell
1,624
-724
-31% -$12.2K ﹤0.01% 430
2022
Q2 		$37K Buy
2,348
+1,074
+84% +$21.1K ﹤0.01% 339
2022
Q1 		$34K Hold
1,274
– – ﹤0.01% 338
2021
Q4 		$50K Sell
1,274
-560
-31% -$22.8K ﹤0.01% 283
2021
Q3 		$88K Buy
1,834
+629
+52% +$28.2K ﹤0.01% 199
2021
Q2 		$41K Buy
+1,205
New +$40.8K ﹤0.01% 208

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ARCT Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Arcturus Therapeutics (ARCT) in Q2 2023, closing a stake of 1,111 shares — an estimated $26.6K sold.

Itau Unibanco Holding S.A. first reported a position in ARCT in Q2 2021 and held it in 8 quarters. The position peaked at $88K in Q3 2021. 143 funds tracked by Wall St. Rank hold ARCT as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Arcturus Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,111 Arcturus Therapeutics shares in Q2 2023, an estimated $26.6K.
  • Itau Unibanco Holding S.A. first reported a position in Arcturus Therapeutics in Q2 2021 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Arcturus Therapeutics position peaked at $88K in Q3 2021.
  • 143 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.